Trump Administration
Refine Search
Pharmaceutical
The Trump administration plans to pull US funding from Gavi, the global vaccine alliance that helps deliver immunizations to children in lower-income countries, according to internal documents obtained by the New York Times. 26 March 2025
Biotechnology
The Trump administration's moves to reduce government funding for the US Food and Drug Administration (FDA) and other agencies, such as the National Institutes of Health, will impact the biotech sector in several important ways, making it likely that companies will seek to combine with peers or be acquired by large pharma players, according to Andrew Goodman, a partner in the M&A practice at law firm Paul Hastings, in a client alert. 22 March 2025
Pharmaceutical
US healthcare giant Johnson & Johnson has announced manufacturing, research and development and technology investments of more than $55 billion in the USA over the next four years. 21 March 2025
Pharmaceutical
Newly-appointed US Health and Human Services (HHS) Secretary Robert F Kennedy Jr has renewed the public health emergency declaration addressing the USA’s opioid crisis, which will allow sustained federal coordination efforts and preserve key flexibilities that enable HHS to continue leveraging expanded authorities to conduct certain activities in response to the opioid overdose crisis. 19 March 2025
Pharmaceutical
Hours before his confirmation hearing, the Trump Administration pulled the nomination of Dr Dave Weldon to be the director of the Centers for Disease Control and Prevention (CDC). 14 March 2025
Pharmaceutical
As the new White House seeks to push ahead with swingeing cuts to government spending, a federal judge in Massachusetts has thrown a wrench in the works. 6 March 2025
Pharmaceutical
The Department of Government Efficiency (DOGE), led by Tesla chief executive Elon Musk, has terminated leases for 30 US Food and Drug Administration facilities across the USA. 5 March 2025
Generics
Even as the spectre of tariffs looms over the pharmaceutical trade between India and the USA, presenting a complex scenario with potential repercussions for both regions, its implementation would necessitate a rapid recalibration of supply chains and pricing strategies, reports The Pharma Letter’s India correspondent. 3 March 2025
Biotechnology
The US President Donald Trump began his second term with a series of directives targeting the US National Institutes of Health (NIH), creating uncertainty around NIH grant funding for biopharmaceutical drug development. 1 March 2025
Pharmaceutical
A pair of Republicans have reintroduced the bicameral Reciprocity Ensures Streamlined Use of Lifesaving Treatments (RESULT) Act. 28 February 2025
Pharmaceutical
The new US President has repealed an executive order from October 2023, signed by the Biden administration, that sought to establish rigorous safeguards for artificial intelligence (AI) development. 22 February 2025
Pharmaceutical
The pharmaceutical industry is preparing for ‘major disruptions’ following US President Donald Trump’s announcement on tariffs, says data and analytics firm GlobalData. 20 February 2025
Pharmaceutical
New US President Donald Trump has started to cut jobs at federal health agencies. 17 February 2025
Pharmaceutical
Robert F.Kennedy Jr. has been confirmed as the new secretary of the Department of Health and Human Services (HHS) after a closely contested vote in the US Senate. 14 February 2025
Pharmaceutical
A federal judge has temporarily blocked the National Institutes of Health (NIH) from implementing research funding cuts in 22 states after a lawsuit argued the move would cripple studies on cancer, Alzheimer’s, and other diseases. 11 February 2025
Pharmaceutical
In a statement on Friday, the USA’s National Institutes of Health (NIH) said it would cut grants for "indirect costs" related to research - such as buildings, utilities and equipment. 10 February 2025
Generics
US President Donald Trump has implemented a series of tariffs on imports from Canada, Mexico and China, but the additional taxes could affect the price Americans pay for generic drugs, with pharma trade groups expressing their fears about the consequences. 4 February 2025
Pharmaceutical
Robert F Kennedy Jr faced pointed questioning during his nomination hearing for secretary of health and human services, as lawmakers sought to reconcile his past controversial statements with the more evidence-based approach he now appears to endorse. 31 January 2025
Pharmaceutical
US public health officials have been ordered to immediately suspend all collaboration with the World Health Organization (WHO) following an executive order by President Donald Trump, which initiates the country’s withdrawal from the global health body. 30 January 2025
Pharmaceutical
New US President Donald Trump and his administration have confirmed that lowering the cost of prescription drugs for Americans is a top priority, suggesting that they will continue the work of the previous regime. 30 January 2025
Pharmaceutical
The Trump administration plans to pull US funding from Gavi, the global vaccine alliance that helps deliver immunizations to children in lower-income countries, according to internal documents obtained by the New York Times. 26 March 2025
Biotechnology
The Trump administration's moves to reduce government funding for the US Food and Drug Administration (FDA) and other agencies, such as the National Institutes of Health, will impact the biotech sector in several important ways, making it likely that companies will seek to combine with peers or be acquired by large pharma players, according to Andrew Goodman, a partner in the M&A practice at law firm Paul Hastings, in a client alert. 22 March 2025
Pharmaceutical
US healthcare giant Johnson & Johnson has announced manufacturing, research and development and technology investments of more than $55 billion in the USA over the next four years. 21 March 2025
Pharmaceutical
Newly-appointed US Health and Human Services (HHS) Secretary Robert F Kennedy Jr has renewed the public health emergency declaration addressing the USA’s opioid crisis, which will allow sustained federal coordination efforts and preserve key flexibilities that enable HHS to continue leveraging expanded authorities to conduct certain activities in response to the opioid overdose crisis. 19 March 2025
Pharmaceutical
Hours before his confirmation hearing, the Trump Administration pulled the nomination of Dr Dave Weldon to be the director of the Centers for Disease Control and Prevention (CDC). 14 March 2025
Pharmaceutical
As the new White House seeks to push ahead with swingeing cuts to government spending, a federal judge in Massachusetts has thrown a wrench in the works. 6 March 2025
Pharmaceutical
The Department of Government Efficiency (DOGE), led by Tesla chief executive Elon Musk, has terminated leases for 30 US Food and Drug Administration facilities across the USA. 5 March 2025
Generics
Even as the spectre of tariffs looms over the pharmaceutical trade between India and the USA, presenting a complex scenario with potential repercussions for both regions, its implementation would necessitate a rapid recalibration of supply chains and pricing strategies, reports The Pharma Letter’s India correspondent. 3 March 2025
Biotechnology
The US President Donald Trump began his second term with a series of directives targeting the US National Institutes of Health (NIH), creating uncertainty around NIH grant funding for biopharmaceutical drug development. 1 March 2025
Pharmaceutical
A pair of Republicans have reintroduced the bicameral Reciprocity Ensures Streamlined Use of Lifesaving Treatments (RESULT) Act. 28 February 2025
Pharmaceutical
The new US President has repealed an executive order from October 2023, signed by the Biden administration, that sought to establish rigorous safeguards for artificial intelligence (AI) development. 22 February 2025
Pharmaceutical
The pharmaceutical industry is preparing for ‘major disruptions’ following US President Donald Trump’s announcement on tariffs, says data and analytics firm GlobalData. 20 February 2025
Pharmaceutical
New US President Donald Trump has started to cut jobs at federal health agencies. 17 February 2025
Pharmaceutical
Robert F.Kennedy Jr. has been confirmed as the new secretary of the Department of Health and Human Services (HHS) after a closely contested vote in the US Senate. 14 February 2025
Pharmaceutical
A federal judge has temporarily blocked the National Institutes of Health (NIH) from implementing research funding cuts in 22 states after a lawsuit argued the move would cripple studies on cancer, Alzheimer’s, and other diseases. 11 February 2025
Pharmaceutical
In a statement on Friday, the USA’s National Institutes of Health (NIH) said it would cut grants for "indirect costs" related to research - such as buildings, utilities and equipment. 10 February 2025
Generics
US President Donald Trump has implemented a series of tariffs on imports from Canada, Mexico and China, but the additional taxes could affect the price Americans pay for generic drugs, with pharma trade groups expressing their fears about the consequences. 4 February 2025
Pharmaceutical
Robert F Kennedy Jr faced pointed questioning during his nomination hearing for secretary of health and human services, as lawmakers sought to reconcile his past controversial statements with the more evidence-based approach he now appears to endorse. 31 January 2025
Pharmaceutical
US public health officials have been ordered to immediately suspend all collaboration with the World Health Organization (WHO) following an executive order by President Donald Trump, which initiates the country’s withdrawal from the global health body. 30 January 2025
Pharmaceutical
New US President Donald Trump and his administration have confirmed that lowering the cost of prescription drugs for Americans is a top priority, suggesting that they will continue the work of the previous regime. 30 January 2025
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Today's issue
Company Spotlight
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze